{
  "url": "https://openlegislation.uk/eu-regulation-2019-2076/annex-II/part-II/division-2/division-5/division-5.3",
  "json_url": "https://openlegislation.uk/eu-regulation-2019-2076/annex-II/part-II/division-2/division-5/division-5.3.json",
  "legislation": "eur/2019/2076",
  "legislation_title": "Commission Implementing Regulation (EU) 2019/2076 of 29 November 2019 granting a Union authorisation for the biocidal product family ‘Contec IPA Product Family’ (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2019-2076",
  "path": "annex/II/part/II/division/2/division/5/division/5.3",
  "kind": "division",
  "number": "5.3",
  "heading": "Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment",
  "text": "Likely direct or indirect adverse effects:\nHeadache, vertigo, hallucinations, respiratory depression, CNS depression or coma.\nSevere irritation of the eyes and or ocular damage.\nNausea, vomiting, diarrhoea and haemorrhagic gastritis.\nPulmonary aspiration hazard may induce pneumonitis, hypotension and hypoglycemia.\nFirst aid measures:\nRelocate the individual from the exposure source and remove any contaminated/spattered clothing articles.\nEye contact: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. If eye irritation persists: Get medical advice/attention\nSkin contact; wash affected area with plenty of water and soap, No scrubbing.\nIn case of ingestion; Do NOT induce vomiting and never give anything by mouth to an impaired or unconscious individual; if the individual is unconscious place individual in left sideways (recovery) position with the head lowered and the knees bent.\nKeep the individual calm and at rest, conserve body temperature and control breathing. If necessary check for pulse and initiate artificial respiration.\nTake the individual to a healthcare centre and bring packaging or label whenever possible.\nNEVER LEAVE THE AFFECTED INDIVIDUAL UNATTENDED!\nAdvice for medical and healthcare personnel:\nMonitor vital signs and provide symptomatic and supportive treatment.\nEvaluate endoscopic procedure in case of ingestion.\nMonitor glycaemia and ketones.\nIpecac use is contraindicated.\nWHEN ASKING FOR MEDICAL ADVICE KEEP PACKAGING OR LABEL AT HAND AND CALL YOUR LOCAL POISON CONTROL CENTRE [INSERT LOCAL NUMBER HERE].",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2019/2076/annex/II/part/II/division/2/division/5/division/5.3",
    "retrieved_at": "2026-11-01T14:42:57.365036+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}